102 related articles for article (PubMed ID: 26759148)
1. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.
Qari H; Hamao-Sakamoto A; Fuselier C; Cheng YS; Kessler H; Wright J
Head Neck Pathol; 2016 Jun; 10(2):192-200. PubMed ID: 26577211
[TBL] [Abstract][Full Text] [Related]
3. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
[TBL] [Abstract][Full Text] [Related]
4. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
Abdulla M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
[TBL] [Abstract][Full Text] [Related]
5. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
[TBL] [Abstract][Full Text] [Related]
6. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
Koga K; Iwasaki H; Nabeshima K
J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
[TBL] [Abstract][Full Text] [Related]
7. Phosphaturic mesenchymal tumor: two cases highlighting differences in clinical and radiologic presentation.
Gu J; Ge C; Joshi G; Most M; Tai R
Skeletal Radiol; 2024 May; 53(5):995-1002. PubMed ID: 37792035
[TBL] [Abstract][Full Text] [Related]
8. Cytological findings of phosphaturic mesenchymal tumor: Report of a case with summary of prior published cases.
Das O; Mohin M; Dey S; Kar A; Singhania P; Adhikari S; Chowdhury S; Chatterjee U
Diagn Cytopathol; 2024 Feb; 52(2):E44-E47. PubMed ID: 37897246
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced osteomalacia treated with T12 tumor resection.
Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of tumor-induced osteomalacia: a single center experience.
Hacisahinogullari H; Tekin S; Tanrikulu S; Saribeyliler G; Yalin GY; Bilgic B; Isik EG; Salduz A; Tuncer S; Gul N; Uzum AK; Aral F; Tanakol R; Selcukbiricik OS
Endocrine; 2023 Nov; 82(2):427-434. PubMed ID: 37480497
[TBL] [Abstract][Full Text] [Related]
11. Phosphaturic Mesenchymal Tumor Along the Hallux side Inducing a Chronic non-Healing Wound: A Case Report with Literature Review.
Sun X; Ni P; Xie T; Wu S
Int J Low Extrem Wounds; 2023 Dec; 22(4):779-787. PubMed ID: 35043721
[TBL] [Abstract][Full Text] [Related]
12. Treatment and Diagnose of Spinal Phosphaturic Mesenchymal Tumor: A Case Report and a Systematic Literature Review.
Chen D; Zhang L; Zhang J; Yin M; Gao X; Huang Q; Li L; Yang X
World Neurosurg; 2024 Apr; 184():65-73. PubMed ID: 38218444
[TBL] [Abstract][Full Text] [Related]
13. RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors.
Liu X; Yin X; Li D; Li K; Zhang H; Lu J; Zhou L; Gao J; Wang J; Wu H; Liang Z
Mod Pathol; 2023 Oct; 36(10):100266. PubMed ID: 37391169
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
[TBL] [Abstract][Full Text] [Related]
15. Intracranial Phosphaturic Mesenchymal Tumors: A Systematic Literature Review of a Rare Entity.
Sánchez Muñoz R; Sanmillan JL; Vidal Sarró N; Martín Quintero G; Martí Duce D; Gabarrós Canals A
World Neurosurg; 2024 Mar; 187():70-81. PubMed ID: 38561034
[TBL] [Abstract][Full Text] [Related]
16. Transformation of a long-standing phosphaturic tumor-inducing osteomalacia into malignancy.
Malagon-Rangel J; Solis JG; Zavala-Jonguitud LF; Basile-Alvarez MR; Malagon-Liceaga A
Clin Case Rep; 2023 Dec; 11(12):e8283. PubMed ID: 38076012
[TBL] [Abstract][Full Text] [Related]
17. Hypophosphataemia-inducing mesenchymal tumour in the foot.
Bauer C; Brücker R; Bützberger S; Schmid C
BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22778109
[TBL] [Abstract][Full Text] [Related]
18. Spinal phosphaturic mesenchymal tumors: a rare etiology causing tumor-induced osteomalacia-a review of experience at a UK tertiary referral center and literature review.
Pannu CD; Baxter D; Anwar H
Eur Spine J; 2023 Nov; ():. PubMed ID: 37964171
[TBL] [Abstract][Full Text] [Related]
19. Adolescent presentation of FGFR1::EBF2 gene fusion mesenchymal tumor.
Jaber O; Sultan I
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23234. PubMed ID: 38593281
[No Abstract] [Full Text] [Related]
20. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
